Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael


Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles


Emergent BioSolutions Will Manufacture AstraZeneca's COVID-19 Vaccine Candidate

The agreement is valued at approximately $87 million.


Sanofi and Denali Halt Clinical Trials of Alzheimer Drug

The companies are shifting their joint efforts from DNL747 to DNL788, which has stronger preclinical data.


3 International Stocks Whose Products You Will Soon Use

Afterpay, Sea Limited, and Blue Prism might be foreign names to a lot of Americans, but these high-growth stocks are bringing products to our country right now.


Is Hasbro Stock a Buy?

In the short term, maybe, but it's doubtful this stock will beat the market long term.


Buy Alert: Novavax Stock Is Heading Higher

Speculators are buying up shares of Novavax, based on a vast market opportunity for its COVID-19 vaccine. But there's even better news that largely mitigates any downside risk.


Is Alnylam Pharmaceuticals a Buy?

The stock is up an amazing 2,100% since the company went public, stomping the S&P 500.


Luckin Coffee Starts Trading Again

The embattled coffee chain in China tries to recover from insider fraud.


2 Top E-Commerce Stocks To Buy in May

Carvana and Sea Limited will dominate internet retail for years to come.


Disrupter Alert: These 2 Companies Are Changing Healthcare As We Know It

Teladoc Health and Livongo Health are using the internet to make our healthcare faster, cheaper, and smarter.


Livongo Health Is Making Money

The stock rose sharply on Thursday after the virtual healthcare specialist beat estimates and unexpectedly achieved profitability in the first quarter.


Adaptive Biotechnologies and Microsoft Announce New Study of COVID-19 Immune Response

The "ImmuneRace" study will genetically map the T-cells of 1,000 people who have been exposed to SARS-CoV-19.


FDA Authorizes Roche's Coronavirus Antibody Test

The new diagnostic tool measures whether a person has developed antibodies for SARS-CoV-2.


2 Small-Cap Stocks With Big-Cap Potential

Here's why Park Hotels & Resorts and Virgin Galactic are strong buys right now.


3 Dirt-Cheap Stocks That Are an Eye-Popping Bargain

Some high-growth names in the beauty and fashion industries are trading at a discount.

FDA Approves Immunomedics' Breast Cancer Drug

Trodelvy is the first treatment approved specifically for triple-negative breast cancer.


Is Beyond Meat Stock a Buy?

The stock is up in 2020, beating the market. But a COVID-19 crash might be on the way.


Disney to Stop Paying 100,000 Employees

The company is trying to save money while its theme parks are closed.


3 Stocks I'm Buying Right Now

In the midst of a global market meltdown, I'm buying virtual companies that are winning market share.


Where Will AMC Be in a Year?

Bottom fishers beware!


Why Is Everyone Talking About OPKO Health Stock?

The pharmaceutical and diagnostics specialist ran into some SEC-related controversy in 2018; now, it's a major player in the fight against COVID-19.